Diabetes Drug Notes
eBook - PDF

Diabetes Drug Notes

  1. English
  2. PDF
  3. Available on iOS & Android
eBook - PDF

About this book

DIABETES DRUG NOTES

Diabetes is becoming more common in both older and younger generations and in keeping with this escalation in cases, there are an ever increasing number of drugs and drug classes that are suitable to treat hyperglycaemia. In a unique blend of diabetes practice, clinical pharmacology, and cardiovascular medicine, Diabetes Drug Notes describes the principles of clinical pharmacology with regards to diabetes prescribing. Each drug class for the treatment of diabetes is covered in detail, along with the effect on the cardiovascular and renal systems caused by each drug. Building upon the success of their "Drug Notes" series for Practical Diabetes and their "Drugs for Diabetes" series in the British Journal of Cardiology, the team of experts focuses on the glycaemic management of type 1 and type 2 diabetes, with other effects of antidiabetic drugs covered as well.

Diabetes Drug Notes also includes:

  • Comprehensive and up-to-date coverage of the drugs for the glycaemic management of patients with type 1 or type 2 diabetes
  • Expert reflection on prescribing considerations for special groups, as well as common pitfalls in prescribing
  • Detailed case histories to illustrate relevant information
  • Summaries of recent guidelines related to diabetic intervention

Diabetes Drug Notes is a user-friendly guide for a general diabetes medical, nursing, and pharmacology readership, as well as those who support them.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Diabetes Drug Notes by Miles Fisher,Gerard A. McKay,Andrea Llano in PDF and/or ePUB format, as well as other popular books in Medicina & Enfermedades y alergias. We have over one million books available in our catalogue for you to explore.

Information

Year
2022
Print ISBN
9781119785002
eBook ISBN
9781119785019

Table of contents

  1. Diabetes Drug Notes
  2. Contents
  3. FOREWORD
  4. PREFACE
  5. EDITORS AND C ONTRIBUTORS
  6. Introduction
  7. 1 Clinical Pharmacology of Antidiabetic Drugs
  8. 2 Metformin
  9. 3 Sulfonylureas and Meglitinides
  10. 4 DPP-4 Inhibitors
  11. 5 SGLT2 Inhibitors
  12. 6 GLP-1 Receptor Agonists
  13. 7 Animal and Human Insulins
  14. 8 Short-acting Insulin Analogues
  15. 9 Long-acting Insulin Analogues
  16. 10 Devices
  17. 11 Acarbose and Alpha Glucosidase Inhibitors
  18. 12 Glitazones and Glitazars
  19. 13 Other Antidiabetic Drugs
  20. 14 Future Antidiabetic Drugs
  21. 15 Guidelines on Antidiabetic Drugs
  22. 16 Prescribing Antidiabetic Drugs
  23. APPENDIX
  24. INDEX
  25. EULA